Acetylcholine Release Inhibitor [EPC]

Acetylcholine Release Inhibitor [EPC] was reported 99109 times

Drugs of the Acetylcholine Release Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MEPHISTO SIGN 68 0.9577
1 BROW PTOSIS 614 0.9360
2 BOTULISM 710 0.8575
3 NEUROMUSCULAR TOXICITY 206 0.5852
4 MULTIPLE USE OF SINGLE-USE PRODUCT 2869 0.5105
5 HEPATIC ENZYME 75 0.5034
6 EYELID SENSORY DISORDER 76 0.3858
7 EYELID PTOSIS 3819 0.3754
8 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 37 0.3558
9 FACIAL ASYMMETRY 338 0.3543
10 FACIAL PARESIS 1032 0.2914
11 LAGOPHTHALMOS 95 0.2323
12 POSTNATAL GROWTH RESTRICTION 30 0.2290
13 FACET JOINT SYNDROME 746 0.2289
14 NEOVASCULARISATION 60 0.2281
15 PRODUCT PREPARATION ERROR 4403 0.2141
16 VASCULAR MALFORMATION 43 0.2048
17 RESIDUAL URINE VOLUME INCREASED 24 0.2034
18 HYPOCHOLESTEROLAEMIA 70 0.1983
19 DERMATOCHALASIS 28 0.1905
20 PARANASAL CYST 44 0.1811
21 CERVICOGENIC HEADACHE 24 0.1765
22 PRODUCT PREPARATION ISSUE 1145 0.1744
23 BLEPHAROSPASM 1052 0.1669
24 OVERLAP SYNDROME 115 0.1643
25 PERIPHERAL VENOUS DISEASE 638 0.1561
26 INJECTION SITE GRANULOMA 33 0.1392
27 SKIN WRINKLING 369 0.1356
28 ONYCHOMADESIS 563 0.1340
29 FACIAL DISCOMFORT 93 0.1312
30 SKIN INDENTATION 59 0.1250
31 BREAST CANCER STAGE III 802 0.1237
32 RHEUMATIC FEVER 548 0.1228
33 LID SULCUS DEEPENED 42 0.1126
34 SWOLLEN JOINT COUNT 28 0.1120
35 DUODENAL ULCER PERFORATION 793 0.1065
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 719 0.1003
37 ONYCHOMYCOSIS 423 0.0963
38 THERAPEUTIC RESPONSE DECREASED 5306 0.0874
39 MUSCLE HYPERTROPHY 30 0.0855
40 MUSCLE INJURY 680 0.0820
41 INFUSION SITE REACTION 242 0.0809
42 CUTIS LAXA 22 0.0809
43 PATIENT DISSATISFACTION WITH TREATMENT 155 0.0804
44 LUPUS VULGARIS 101 0.0802
45 FACIAL SPASM 89 0.0795
46 MIGRAINE WITHOUT AURA 23 0.0767
47 FOLLICULITIS 801 0.0763
48 LIVE BIRTH 625 0.0746
49 HELICOBACTER INFECTION 765 0.0744
50 FINGER DEFORMITY 355 0.0732
51 LIP DRY 665 0.0731
52 NAIL DISORDER 640 0.0731
53 POST-TRAUMATIC NECK SYNDROME 58 0.0717
54 PRODUCT ADMINISTERED BY WRONG PERSON 27 0.0707
55 SKIN TIGHTNESS 330 0.0701
56 INJECTION SITE OEDEMA 118 0.0686
57 BURSITIS 826 0.0680
58 HYPERCHOLESTEROLAEMIA 653 0.0676
59 OCCIPITAL NEURALGIA 38 0.0673
60 PEMPHIGUS 837 0.0669
61 WOUND INFECTION 718 0.0655
62 EXTRAOCULAR MUSCLE PARESIS 30 0.0654
63 DRUG SPECIFIC ANTIBODY 89 0.0650
64 C-REACTIVE PROTEIN 60 0.0647
65 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35 0.0624
66 SKIN LAXITY 27 0.0616
67 C-REACTIVE PROTEIN ABNORMAL 393 0.0612
68 INCORRECT PRODUCT FORMULATION ADMINISTERED 54 0.0610
69 X-RAY ABNORMAL 107 0.0598
70 SOFT TISSUE INJURY 45 0.0594
71 HAND DEFORMITY 778 0.0593
72 DISLOCATION OF VERTEBRA 135 0.0591
73 FACIAL PARALYSIS 492 0.0577
74 GRIP STRENGTH DECREASED 505 0.0573
75 EYELID FUNCTION DISORDER 45 0.0569
76 INJECTION SITE HYPOAESTHESIA 81 0.0566
77 DEEP VEIN THROMBOSIS POSTOPERATIVE 113 0.0564
78 PRODUCT LABEL CONFUSION 328 0.0562
79 PERIORBITAL SWELLING 311 0.0549
80 BACK INJURY 596 0.0547
81 HYPOAESTHESIA EYE 32 0.0542
82 JOINT RANGE OF MOTION DECREASED 685 0.0510
83 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 105 0.0506
84 INJECTION SITE PARAESTHESIA 77 0.0501
85 POOR QUALITY PRODUCT ADMINISTERED 523 0.0496
86 MASTICATION DISORDER 151 0.0493
87 PERICARDITIS 827 0.0492
88 TORTICOLLIS 102 0.0481
89 MASTOIDITIS 47 0.0479
90 REDUCED FACIAL EXPRESSION 47 0.0463
91 MANUFACTURING PRODUCT SHIPPING ISSUE 25 0.0460
92 EYELID DISORDER 106 0.0459
93 SYNOVITIS 822 0.0455
94 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1642 0.0452
95 THERAPEUTIC RESPONSE SHORTENED 1466 0.0442
96 SWOLLEN JOINT COUNT INCREASED 139 0.0435
97 COELIAC DISEASE 426 0.0434
98 EYELID OEDEMA 501 0.0431
99 FACIAL PAIN 384 0.0430
100 LIP DISORDER 81 0.0427
101 DRUG EFFECT LESS THAN EXPECTED 626 0.0422
102 PHARYNGEAL HYPOAESTHESIA 38 0.0409
103 TASTE DISORDER 812 0.0400
104 OPHTHALMOPLEGIA 63 0.0399
105 OBESITY 624 0.0391
106 THERAPEUTIC PRODUCT EFFECT DECREASED 1730 0.0386
107 TONGUE PARALYSIS 27 0.0379
108 RETINITIS 65 0.0376
109 PRODUCT TEMPERATURE EXCURSION ISSUE 192 0.0373
110 MIGRAINE 3565 0.0373
111 PORPHYRIA ACUTE 53 0.0369
112 SWELLING OF EYELID 232 0.0369
113 EYE CONTUSION 78 0.0369
114 BONE EROSION 130 0.0367
115 GLOSSODYNIA 815 0.0364
116 PRODUCT USED FOR UNKNOWN INDICATION 45 0.0357
117 STERNAL FRACTURE 44 0.0357
118 SUSPECTED PRODUCT QUALITY ISSUE 65 0.0355
119 ASTHENOPIA 190 0.0345
120 VIITH NERVE PARALYSIS 118 0.0342
121 FIBROMYALGIA 829 0.0341
122 EPILEPSY 1042 0.0341
123 HYPOAESTHESIA FACIAL 51 0.0339
124 NECK PAIN 1890 0.0338
125 TENSION HEADACHE 145 0.0337
126 IRRITABLE BOWEL SYNDROME 711 0.0331
127 CONGENITAL ANOMALY 252 0.0325
128 PERIORBITAL OEDEMA 164 0.0316
129 ACCOMMODATION DISORDER 22 0.0301
130 DIPLOPIA 768 0.0295
131 FACIAL PALSY 62 0.0287
132 ADVERSE REACTION 375 0.0283
133 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 75 0.0282
134 INJECTION SITE INDENTATION 61 0.0281
135 WOUND 774 0.0277
136 ENDOMETRIOSIS 132 0.0277
137 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 473 0.0276
138 STRABISMUS 79 0.0269
139 INJECTION SITE PAPULE 120 0.0262
140 VOCAL CORD PARALYSIS 47 0.0262
141 SENSATION OF PRESSURE 23 0.0260
142 SYSTEMIC LUPUS ERYTHEMATOSUS 919 0.0259
143 MUSCULAR WEAKNESS 2925 0.0257
144 LIVER INJURY 627 0.0255
145 DYSPHAGIA 2409 0.0254
146 DRUG INEFFECTIVE 33273 0.0252
147 POSTURE ABNORMAL 82 0.0252
148 TYPE 2 DIABETES MELLITUS 845 0.0251
149 SWELLING FACE 1619 0.0248
150 NORMAL NEWBORN 134 0.0246
151 HEAD DISCOMFORT 431 0.0243
152 BLADDER SPASM 45 0.0240
153 INJECTION SITE HYPERSENSITIVITY 75 0.0240
154 POOR QUALITY DRUG ADMINISTERED 155 0.0239
155 DARK CIRCLES UNDER EYES 35 0.0238
156 CONTRAINDICATED PRODUCT ADMINISTERED 718 0.0237
157 COUNTERFEIT PRODUCT ADMINISTERED 30 0.0230
158 EYE SWELLING 851 0.0229
159 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1255 0.0228
160 LIVER FUNCTION TEST INCREASED 486 0.0226
161 RHEUMATOID FACTOR POSITIVE 130 0.0225
162 GAIT INABILITY 751 0.0224
163 MUSCLE SPASTICITY 274 0.0223
164 LIBIDO INCREASED 45 0.0222
165 PSORIATIC ARTHROPATHY 898 0.0221
166 INJECTION SITE INFLAMMATION 110 0.0221
167 C-REACTIVE PROTEIN INCREASED 795 0.0218
168 GESTATIONAL HYPERTENSION 28 0.0217
169 AUTOIMMUNE DISORDER 208 0.0213
170 EYELID PAIN 43 0.0211
171 OFF LABEL USE 18529 0.0211
172 IMPAIRED HEALING 693 0.0211
173 SEDATION 549 0.0209
174 INJECTION SITE SWELLING 1592 0.0208
175 MUSCLE TIGHTNESS 336 0.0207
176 NIGHT SWEATS 654 0.0203
177 PRESCRIBED OVERDOSE 390 0.0201
178 PARADOXICAL DRUG REACTION 74 0.0201
179 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 27 0.0200
180 THERAPEUTIC RESPONSE DELAYED 55 0.0196
181 HEAD TITUBATION 27 0.0196
182 CYSTITIS NONINFECTIVE 26 0.0194
183 PARALYSIS 273 0.0191
184 HYPERACUSIS 68 0.0183
185 ELECTRIC SHOCK SENSATION 51 0.0182
186 MUSCLE CONTRACTIONS INVOLUNTARY 63 0.0179
187 MUSCLE TWITCHING 412 0.0179
188 INFLAMMATION 921 0.0178
189 INJECTION SITE NODULE 195 0.0177
190 ABNORMAL SENSATION IN EYE 76 0.0177
191 MIGRAINE WITH AURA 48 0.0176
192 EXOSTOSIS 161 0.0176
193 PERSONALITY DISORDER 46 0.0175
194 TRISMUS 90 0.0174
195 OSTEOARTHRITIS 737 0.0174
196 HOSTILITY 44 0.0173
197 BREAST CANCER STAGE II 144 0.0173
198 MAST CELL ACTIVATION SYNDROME 24 0.0171
199 OTITIS MEDIA 56 0.0169
200 PARANASAL SINUS DISCOMFORT 64 0.0169
201 DRY MOUTH 1364 0.0168
202 DRUG TOLERANCE 85 0.0168
203 INJECTION SITE RASH 515 0.0168
204 SUSPECTED COUNTERFEIT PRODUCT 66 0.0167
205 BLOOD CHOLESTEROL INCREASED 775 0.0166
206 HYPERTONIC BLADDER 48 0.0166
207 PHOTOPHOBIA 312 0.0166
208 SWELLING 1533 0.0164
209 ARTHROPATHY 891 0.0160
210 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1138 0.0160
211 INJECTION SITE DISCOMFORT 168 0.0160
212 TRIGEMINAL NEURALGIA 64 0.0159
213 HYPOAESTHESIA ORAL 239 0.0158
214 INJECTION SITE ATROPHY 26 0.0158
215 NIGHTMARE 547 0.0158
216 MUSCULOSKELETAL PAIN 826 0.0158
217 TEMPOROMANDIBULAR JOINT SYNDROME 42 0.0157
218 MUSCLE ATROPHY 197 0.0155
219 DRUG INTOLERANCE 1501 0.0155
220 DROOLING 107 0.0155
221 BLISTER 869 0.0155
222 LOWER RESPIRATORY TRACT INFECTION 700 0.0154
223 PREGNANCY 305 0.0152
224 MATERNAL EXPOSURE TIMING UNSPECIFIED 57 0.0152
225 INJECTION RELATED REACTION 25 0.0151
226 DRUG-INDUCED LIVER INJURY 475 0.0151
227 DYSPHONIA 882 0.0151
228 PRODUCT STORAGE ERROR 1311 0.0150
229 HYPOAESTHESIA 2236 0.0149
230 NERVE INJURY 165 0.0148
231 EYE INJURY 45 0.0148
232 INJECTION SITE MASS 547 0.0148
233 INFLUENZA LIKE ILLNESS 1200 0.0146
234 HEPATITIS 372 0.0145
235 EAR DISCOMFORT 147 0.0143
236 INJECTION SITE INFECTION 47 0.0143
237 PRODUCT DISTRIBUTION ISSUE 132 0.0142
238 CONCUSSION 110 0.0142
239 ULCER HAEMORRHAGE 95 0.0140
240 GASTROOESOPHAGEAL REFLUX DISEASE 1126 0.0140
241 INJECTION SITE PAIN 4288 0.0140
242 MASS 195 0.0139
243 AURA 26 0.0139
244 THERAPEUTIC PRODUCT EFFECT VARIABLE 54 0.0139
245 EYE MOVEMENT DISORDER 95 0.0139
246 RED BLOOD CELL SEDIMENTATION RATE INCREASED 153 0.0138
247 NEUROGENIC BLADDER 29 0.0137
248 TENDERNESS 143 0.0137
249 LUNG DISORDER 665 0.0136
250 MATERNAL EXPOSURE DURING PREGNANCY 1202 0.0135
251 VISION BLURRED 1851 0.0135
252 EAR PAIN 262 0.0135
253 INDURATION 24 0.0135
254 SWOLLEN TONGUE 418 0.0134
255 ATROPHY 26 0.0134
256 OCULAR DISCOMFORT 150 0.0133
257 NASAL OEDEMA 24 0.0133
258 INFUSION RELATED REACTION 880 0.0133
259 WHEEZING 772 0.0130
260 BLADDER PAIN 41 0.0129
261 SINUS PAIN 30 0.0129
262 MUSCULOSKELETAL STIFFNESS 1126 0.0128
263 STOMATITIS 773 0.0127
264 MUSCLE DISORDER 103 0.0127
265 DRY EYE 634 0.0127
266 VOCAL CORD DISORDER 25 0.0127
267 URINARY RETENTION 422 0.0126
268 PARESIS 28 0.0126
269 ERYTHEMA OF EYELID 67 0.0124
270 URINARY BLADDER HAEMORRHAGE 26 0.0123
271 EYE OEDEMA 30 0.0122
272 MONOPLEGIA 52 0.0120
273 CHOKING SENSATION 66 0.0120
274 PARAESTHESIA 1879 0.0119
275 INJECTION SITE SCAR 34 0.0119
276 SPEECH DISORDER 621 0.0118
277 THERAPEUTIC PRODUCT EFFECT DELAYED 53 0.0116
278 NECK SURGERY 27 0.0116
279 INJECTION SITE URTICARIA 283 0.0115
280 NEPHROLITHIASIS 526 0.0115
281 HYPOTONIA 114 0.0114
282 NODULE 149 0.0114
283 MOBILITY DECREASED 818 0.0114
284 VASCULAR OCCLUSION 24 0.0114
285 INTENTIONAL PRODUCT USE ISSUE 995 0.0113
286 SENSATION OF HEAVINESS 44 0.0113
287 EYELID IRRITATION 28 0.0112
288 ASPIRATION 122 0.0111
289 CHOKING 216 0.0111
290 HEPATIC ENZYME INCREASED 752 0.0110
291 THROAT TIGHTNESS 298 0.0110
292 LACRIMATION INCREASED 332 0.0110
293 DISCOMFORT 670 0.0110
294 EYELIDS PRURITUS 34 0.0109
295 EYE DISCHARGE 112 0.0108
296 RASH VESICULAR 52 0.0107
297 INJECTION SITE REACTION 738 0.0107
298 THERAPY NON-RESPONDER 480 0.0107
299 LUPUS-LIKE SYNDROME 96 0.0106
300 GUILLAIN-BARRE SYNDROME 51 0.0105
301 GENERAL PHYSICAL CONDITION ABNORMAL 71 0.0105
302 DYSARTHRIA 394 0.0105
303 WALKING AID USER 69 0.0105
304 LIP PAIN 30 0.0104
305 MYASTHENIA GRAVIS 83 0.0103
306 AUTONOMIC NERVOUS SYSTEM IMBALANCE 30 0.0103
307 AMYOTROPHIC LATERAL SCLEROSIS 22 0.0102
308 MUSCLE FATIGUE 43 0.0101
309 SLEEP DISORDER 711 0.0101
310 FINE MOTOR SKILL DYSFUNCTION 29 0.0100
311 BURNING SENSATION 701 0.0100
312 DRUG TOLERANCE DECREASED 28 0.0100
313 EXPOSURE DURING PREGNANCY 614 0.0099
314 SPINAL FUSION SURGERY 40 0.0098
315 SENSATION OF FOREIGN BODY 83 0.0098
316 SENSORY DISTURBANCE 158 0.0098
317 NEURALGIA 238 0.0098
318 INJECTION SITE VESICLES 59 0.0097
319 PRODUCT QUALITY ISSUE 1318 0.0097
320 HEADACHE 6069 0.0097
321 PUSTULAR PSORIASIS 33 0.0096
322 SKIN MASS 64 0.0096
323 VISUAL FIELD DEFECT 69 0.0095
324 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 62 0.0095
325 LOWER LIMB FRACTURE 183 0.0095
326 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1920 0.0095
327 SLOW SPEECH 23 0.0095
328 RHINALGIA 26 0.0095
329 JOINT DISLOCATION 100 0.0095
330 BRAIN FOG 148 0.0094
331 AREFLEXIA 25 0.0094
332 URTICARIA 1559 0.0093
333 FOOD INTOLERANCE 34 0.0093
334 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 170 0.0093
335 IMPAIRED DRIVING ABILITY 105 0.0092
336 DRUG SPECIFIC ANTIBODY PRESENT 60 0.0092
337 DRUG ADMINISTERED AT INAPPROPRIATE SITE 97 0.0092
338 VITREOUS FLOATERS 90 0.0091
339 JAW DISORDER 50 0.0091
340 URINARY INCONTINENCE 266 0.0090
341 BLEPHARITIS 36 0.0090
342 EYE DISORDER 295 0.0090
343 PHYSICAL DECONDITIONING 23 0.0089
344 MENOPAUSE 23 0.0089
345 TREATMENT FAILURE 737 0.0089
346 MATERNAL EXPOSURE DURING BREAST FEEDING 36 0.0089
347 EYE PAIN 500 0.0089
348 HYPERSENSITIVITY 1641 0.0088
349 STRIDOR 26 0.0088
350 LIP SWELLING 294 0.0088
351 VERTIGO 532 0.0087
352 CONTUSION 840 0.0087
353 PHARYNGEAL DISORDER 25 0.0087
354 IMPAIRED WORK ABILITY 184 0.0086
355 PANIC REACTION 62 0.0086
356 PANIC ATTACK 313 0.0086
357 OCCUPATIONAL EXPOSURE TO PRODUCT 55 0.0085
358 TINNITUS 393 0.0085
359 MUSCLE SPASMS 1563 0.0085
360 SCIATICA 135 0.0085
361 DEAFNESS UNILATERAL 46 0.0083
362 PRE-EXISTING CONDITION IMPROVED 52 0.0083
363 INJECTION SITE DISCOLOURATION 104 0.0083
364 HORDEOLUM 36 0.0083
365 ILL-DEFINED DISORDER 502 0.0083
366 PRODUCT USE IN UNAPPROVED INDICATION 2047 0.0083
367 SPONDYLITIS 30 0.0082
368 MEMORY IMPAIRMENT 1129 0.0082
369 INJURY 575 0.0082
370 ANGIOEDEMA 361 0.0082
371 BRUXISM 44 0.0082
372 RHEUMATOID ARTHRITIS 924 0.0081
373 PHOTOPSIA 51 0.0081
374 GENERAL PHYSICAL HEALTH DETERIORATION 931 0.0080
375 FOREIGN BODY SENSATION IN EYES 50 0.0078
376 PULMONARY FIBROSIS 150 0.0078
377 INJECTION SITE HAEMATOMA 113 0.0078
378 SKIN DISORDER 258 0.0077
379 INJECTION SITE ERYTHEMA 957 0.0077
380 DYSPEPSIA 752 0.0076
381 PAIN IN JAW 216 0.0076
382 MADAROSIS 88 0.0076
383 BRAIN INJURY 76 0.0076
384 SINUS HEADACHE 45 0.0076
385 APHONIA 105 0.0075
386 GRANULOMA 26 0.0075
387 PARAESTHESIA ORAL 108 0.0075
388 FACE INJURY 28 0.0074
389 BLADDER DISORDER 73 0.0073
390 INJECTION SITE BRUISING 584 0.0073
391 ANURIA 63 0.0073
392 INCORRECT PRODUCT STORAGE 96 0.0073
393 PRODUCT CONTAMINATION 26 0.0073
394 HYPERAESTHESIA 60 0.0073
395 PRESCRIBED UNDERDOSE 144 0.0072
396 PERONEAL NERVE PALSY 41 0.0072
397 GASTROINTESTINAL DISORDER 641 0.0071
398 RESPIRATORY DISORDER 212 0.0071
399 INJECTION SITE PRURITUS 474 0.0071
400 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 339 0.0071
401 CONFUSIONAL STATE 1135 0.0070
402 NEUROLOGICAL SYMPTOM 40 0.0070
403 HYPERHIDROSIS 900 0.0070
404 JOINT STIFFNESS 183 0.0070
405 LEFT VENTRICULAR FAILURE 24 0.0070
406 PAPULE 49 0.0069
407 BLINDNESS TRANSIENT 51 0.0069
408 FACE OEDEMA 116 0.0069
409 AUTOIMMUNE THYROIDITIS 26 0.0069
410 PRODUCT SUPPLY ISSUE 49 0.0069
411 DRUG RESISTANCE 176 0.0068
412 PRODUCT PACKAGING ISSUE 65 0.0068
413 HYPERTONIA 39 0.0068
414 MOUTH SWELLING 39 0.0068
415 MYOSITIS 60 0.0067
416 PRODUCT CONTAINER ISSUE 57 0.0066
417 JOINT SWELLING 800 0.0066
418 SKIN ODOUR ABNORMAL 26 0.0066
419 NYSTAGMUS 35 0.0066
420 ALOPECIA 1290 0.0066
421 MUSCULOSKELETAL DISCOMFORT 113 0.0066
422 MYDRIASIS 84 0.0065
423 SPINAL STENOSIS 27 0.0065
424 INCONTINENCE 69 0.0065
425 DEFORMITY 61 0.0065
426 SALIVARY HYPERSECRETION 65 0.0065
427 SPINAL OPERATION 80 0.0065
428 APHASIA 196 0.0065
429 MICTURITION URGENCY 74 0.0065
430 INJECTION SITE INDURATION 83 0.0064
431 ASTHENIA 2401 0.0064
432 PRODUCT ADMINISTRATION INTERRUPTED 50 0.0064
433 TONGUE DISORDER 46 0.0064
434 OROPHARYNGEAL DISCOMFORT 57 0.0063
435 EXPOSURE VIA BREAST MILK 25 0.0063
436 MUSCLE STRAIN 54 0.0062
437 VISUAL IMPAIRMENT 773 0.0062
438 OESOPHAGEAL DISORDER 24 0.0062
439 PAROSMIA 47 0.0062
440 PNEUMONIA ASPIRATION 155 0.0062
441 SUSPECTED OFF LABEL USE 28 0.0062
442 DEPRESSION 1407 0.0062
443 ADVERSE DRUG REACTION 553 0.0062
444 DYSPHEMIA 27 0.0062
445 DIZZINESS 3054 0.0061
446 PARTIAL SEIZURES 32 0.0061
447 OCULAR HYPERAEMIA 288 0.0061
448 RASH PAPULAR 135 0.0060
449 IMPAIRED GASTRIC EMPTYING 82 0.0060
450 DISABILITY 118 0.0060
451 SENSORY LOSS 48 0.0060
452 HEPATIC CIRRHOSIS 112 0.0060
453 ABDOMINAL DISCOMFORT 998 0.0059
454 DYSTONIA 115 0.0059
455 PHARYNGEAL SWELLING 58 0.0059
456 HYPERTENSION 1254 0.0059
457 PHARYNGEAL OEDEMA 91 0.0059
458 PERIPHERAL SWELLING 904 0.0059
459 ROAD TRAFFIC ACCIDENT 245 0.0059
460 EYE INFECTION 66 0.0058
461 ABDOMINAL PAIN UPPER 1191 0.0058
462 MUSCULOSKELETAL DISORDER 109 0.0057
463 EYE PRURITUS 192 0.0057
464 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97 0.0057
465 DRY THROAT 58 0.0057
466 SKIN HYPERPIGMENTATION 49 0.0057
467 PRESYNCOPE 137 0.0056
468 SCAR 95 0.0055
469 FEEDING DISORDER 112 0.0055
470 SURGERY 323 0.0055
471 DYSGRAPHIA 36 0.0055
472 EYE OPERATION 25 0.0054
473 LYMPHADENOPATHY 192 0.0054
474 NASAL DISCOMFORT 43 0.0054
475 INJECTION SITE IRRITATION 69 0.0054
476 ADVERSE EVENT 499 0.0054
477 FOOT DEFORMITY 60 0.0054
478 BEDRIDDEN 71 0.0054
479 HERPES VIRUS INFECTION 31 0.0054
480 SHOULDER OPERATION 23 0.0054
481 UNDERDOSE 391 0.0054
482 NASOPHARYNGITIS 987 0.0053
483 SKIN WARM 31 0.0053
484 FOOD ALLERGY 41 0.0053
485 FEELING HOT 325 0.0053
486 MOTOR DYSFUNCTION 54 0.0053
487 ABDOMINAL DISTENSION 553 0.0053
488 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
489 INJECTION SITE INJURY 29 0.0052
490 ON AND OFF PHENOMENON 29 0.0052
491 PAIN 3204 0.0052
492 DRUG EFFECT DECREASED 280 0.0052
493 FORMICATION 36 0.0052
494 SINUS DISORDER 102 0.0051
495 DYSKINESIA 209 0.0051
496 SINUSITIS 527 0.0051
497 POOR QUALITY SLEEP 110 0.0051
498 HEMIPARESIS 86 0.0051
499 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 361 0.0051
500 POST-TRAUMATIC STRESS DISORDER 34 0.0051
501 WRONG PRODUCT ADMINISTERED 34 0.0050
502 ODYNOPHAGIA 30 0.0050
503 PHOTOSENSITIVITY REACTION 83 0.0050
504 INTRACRANIAL PRESSURE INCREASED 28 0.0050
505 INCORRECT PRODUCT ADMINISTRATION DURATION 108 0.0050
506 MATERNAL EXPOSURE BEFORE PREGNANCY 34 0.0050
507 ANXIETY 1414 0.0050
508 ROSACEA 23 0.0049
509 ANAL INCONTINENCE 44 0.0049
510 SINUS CONGESTION 66 0.0049
511 SKIN DISCOLOURATION 224 0.0049
512 DYSSTASIA 142 0.0049
513 MOVEMENT DISORDER 156 0.0049
514 FEELING DRUNK 36 0.0048
515 AMNESIA 315 0.0048
516 GENERAL SYMPTOM 36 0.0048
517 LIMB OPERATION 23 0.0048
518 FAECAL INCONTINENCE 23 0.0048
519 PALPITATIONS 560 0.0048
520 HYDROCEPHALUS 26 0.0048
521 OVERDOSE 1027 0.0048
522 HYPOKINESIA 69 0.0047
523 PRODUCT ADMINISTRATION ERROR 96 0.0047
524 UPPER RESPIRATORY TRACT INFECTION 219 0.0047
525 DERMATITIS CONTACT 54 0.0047
526 CONDITION AGGRAVATED 1434 0.0047
527 HORMONE LEVEL ABNORMAL 23 0.0047
528 INSOMNIA 1251 0.0047
529 INCREASED UPPER AIRWAY SECRETION 24 0.0047
530 ORAL DISORDER 34 0.0046
531 HYSTERECTOMY 40 0.0046
532 CYSTITIS 147 0.0046
533 INTENTIONAL PRODUCT MISUSE 404 0.0046
534 PRODUCT USE ISSUE 867 0.0046
535 UPPER-AIRWAY COUGH SYNDROME 38 0.0046
536 FEELING OF BODY TEMPERATURE CHANGE 27 0.0046
537 TENSION 28 0.0046
538 VEIN DISORDER 23 0.0046
539 EAR INFECTION 122 0.0046
540 RASH 1987 0.0046
541 EYE IRRITATION 262 0.0045
542 TOOTHACHE 82 0.0045
543 SKIN ATROPHY 26 0.0045
544 MUSCLE RIGIDITY 54 0.0045
545 HYPERVENTILATION 26 0.0045
546 DYSPNOEA 2536 0.0045
547 BODY TEMPERATURE INCREASED 91 0.0045
548 ARTHROPOD BITE 33 0.0044
549 HEMIPLEGIA 37 0.0044
550 SPINAL PAIN 52 0.0044
551 POST PROCEDURAL COMPLICATION 85 0.0044
552 BALANCE DISORDER 381 0.0044
553 ASTHMA 498 0.0044
554 ERYTHEMA 904 0.0044
555 ORAL DISCOMFORT 61 0.0044
556 OROPHARYNGEAL PAIN 406 0.0044
557 IMPAIRED QUALITY OF LIFE 63 0.0044
558 NONSPECIFIC REACTION 24 0.0044
559 INJECTION SITE WARMTH 89 0.0043
560 CEREBRAL DISORDER 32 0.0043
561 SPINAL OSTEOARTHRITIS 38 0.0043
562 FEELING ABNORMAL 1035 0.0043
563 PRODUCT DISPENSING ERROR 94 0.0043
564 NAUSEA 3411 0.0043
565 DISTURBANCE IN ATTENTION 232 0.0043
566 WEIGHT FLUCTUATION 45 0.0043
567 PALLOR 117 0.0043
568 WEIGHT INCREASED 962 0.0043
569 MIDDLE INSOMNIA 80 0.0043
570 THERAPEUTIC RESPONSE UNEXPECTED 192 0.0043
571 CHEILITIS 23 0.0042
572 HIP ARTHROPLASTY 65 0.0042
573 OEDEMA 230 0.0042
574 LIMB DISCOMFORT 131 0.0042
575 INTERVERTEBRAL DISC DEGENERATION 39 0.0042
576 VISUAL ACUITY REDUCED 140 0.0042
577 MULTIPLE ALLERGIES 33 0.0042
578 SLEEP APNOEA SYNDROME 80 0.0042
579 INSURANCE ISSUE 64 0.0042
580 TREMOR 694 0.0042
581 GAIT DISTURBANCE 799 0.0042
582 CHEST DISCOMFORT 427 0.0042
583 THERAPY PARTIAL RESPONDER 65 0.0042
584 NASAL DRYNESS 26 0.0041
585 BRAIN NEOPLASM 38 0.0041
586 MULTIPLE SCLEROSIS 197 0.0041
587 RASH PUSTULAR 30 0.0041
588 CYST 51 0.0041
589 INCORRECT ROUTE OF DRUG ADMINISTRATION 146 0.0041
590 SEIZURE 470 0.0041
591 URINARY TRACT INFECTION 691 0.0040
592 SCOLIOSIS 25 0.0040
593 SCAB 46 0.0040
594 SKIN SWELLING 35 0.0040
595 SEASONAL ALLERGY 57 0.0040
596 ACTIVITIES OF DAILY LIVING IMPAIRED 78 0.0039
597 ARTERIOSCLEROSIS CORONARY ARTERY 26 0.0039
598 FATIGUE 3049 0.0039
599 NERVE COMPRESSION 36 0.0039
600 GINGIVAL PAIN 31 0.0039
601 THROAT IRRITATION 173 0.0039
602 SYMPTOM RECURRENCE 23 0.0038
603 PRODUCT LABEL ISSUE 26 0.0038
604 DYSURIA 141 0.0038
605 BLINDNESS UNILATERAL 54 0.0038
606 IMMUNODEFICIENCY 57 0.0038
607 BACK DISORDER 62 0.0038
608 KNEE ARTHROPLASTY 80 0.0038
609 RIB FRACTURE 78 0.0038
610 VOMITING 1781 0.0038
611 TEMPERATURE INTOLERANCE 39 0.0038
612 MALAISE 1657 0.0038
613 DELIRIUM 131 0.0038
614 SECRETION DISCHARGE 47 0.0037
615 MENSTRUAL DISORDER 31 0.0037
616 PAIN IN EXTREMITY 1099 0.0037
617 UNEVALUABLE EVENT 282 0.0037
618 PRODUCT PHYSICAL ISSUE 75 0.0037
619 NERVOUS SYSTEM DISORDER 116 0.0037
620 ANAPHYLACTIC REACTION 205 0.0037
621 INITIAL INSOMNIA 38 0.0037
622 COLD SWEAT 65 0.0037
623 VIRAL INFECTION 122 0.0037
624 EATING DISORDER 78 0.0037
625 ANOSMIA 53 0.0037
626 PERIPHERAL COLDNESS 50 0.0036
627 FALL 1211 0.0036
628 VITAMIN D DECREASED 31 0.0036
629 INJECTION SITE HAEMORRHAGE 289 0.0036
630 SNEEZING 81 0.0036
631 FOETAL EXPOSURE DURING PREGNANCY 293 0.0036
632 FREQUENT BOWEL MOVEMENTS 97 0.0036
633 BLINDNESS 146 0.0036
634 MYALGIA 607 0.0036
635 POST PROCEDURAL INFECTION 29 0.0036
636 EYE INFLAMMATION 34 0.0036
637 LOCAL SWELLING 62 0.0036
638 DRUG EFFECT INCOMPLETE 129 0.0035
639 PNEUMONIA 1143 0.0035
640 DENTAL CARIES 39 0.0035
641 ARTHRALGIA 1460 0.0035
642 OSTEOPOROSIS 143 0.0035
643 LETHARGY 200 0.0035
644 HEAD INJURY 110 0.0035
645 APNOEA 27 0.0035
646 MENTAL IMPAIRMENT 84 0.0035
647 RASH ERYTHEMATOUS 165 0.0034
648 HERPES ZOSTER 198 0.0034
649 DECUBITUS ULCER 28 0.0034
650 INTERVERTEBRAL DISC PROTRUSION 75 0.0034
651 ASPHYXIA 28 0.0034
652 SKIN LACERATION 37 0.0034
653 PROCEDURAL COMPLICATION 26 0.0034
654 PRURITUS GENERALISED 73 0.0034
655 HEART RATE INCREASED 332 0.0033
656 BIPOLAR DISORDER 36 0.0033
657 CHEST PAIN 611 0.0033
658 LIQUID PRODUCT PHYSICAL ISSUE 24 0.0033
659 ATAXIA 39 0.0033
660 RESPIRATORY TRACT INFECTION 85 0.0033
661 RETINAL DETACHMENT 30 0.0033
662 IMMUNE SYSTEM DISORDER 43 0.0033
663 UROSEPSIS 30 0.0032
664 COGNITIVE DISORDER 151 0.0032
665 WEIGHT DECREASED 900 0.0032
666 FRUSTRATION TOLERANCE DECREASED 26 0.0032
667 LOSS OF CONSCIOUSNESS 412 0.0032
668 DIZZINESS POSTURAL 31 0.0032
669 ILLNESS 328 0.0032
670 RASH GENERALISED 82 0.0032
671 PRODUCT COMPLAINT 80 0.0032
672 DISORIENTATION 125 0.0032
673 ARTHRITIS 248 0.0031
674 DEAFNESS 82 0.0031
675 RESTLESS LEGS SYNDROME 57 0.0031
676 THIRST 56 0.0031
677 SKIN INFECTION 35 0.0031
678 SENSITIVE SKIN 23 0.0031
679 THINKING ABNORMAL 58 0.0031
680 DYSGEUSIA 231 0.0031
681 EXTRAPYRAMIDAL DISORDER 77 0.0031
682 ACCIDENTAL EXPOSURE TO PRODUCT 319 0.0031
683 TOOTH FRACTURE 34 0.0031
684 LACERATION 29 0.0031
685 CONJUNCTIVITIS 57 0.0031
686 PRURITUS 1180 0.0031
687 KNEE OPERATION 30 0.0030
688 PHARYNGITIS STREPTOCOCCAL 33 0.0030
689 NEPHROPATHY TOXIC 34 0.0030
690 INFUSION SITE PAIN 39 0.0030
691 HEART RATE IRREGULAR 68 0.0030
692 KIDNEY INFECTION 59 0.0030
693 CARPAL TUNNEL SYNDROME 42 0.0030
694 THYROID DISORDER 46 0.0030
695 FEAR 80 0.0030
696 VITAMIN D DEFICIENCY 29 0.0030
697 POISONING 37 0.0029
698 CELLULITIS 148 0.0029
699 PAIN OF SKIN 79 0.0029
700 LIGAMENT SPRAIN 29 0.0029
701 AGEUSIA 73 0.0029
702 RENAL PAIN 31 0.0029
703 ABORTION SPONTANEOUS 117 0.0029
704 PYREXIA 1010 0.0029
705 CRYING 106 0.0029
706 INFLUENZA 322 0.0029
707 DERMATITIS ALLERGIC 36 0.0029
708 CHILLS 334 0.0028
709 DECREASED APPETITE 661 0.0028
710 BACK PAIN 660 0.0028
711 FEELING COLD 79 0.0028
712 RESPIRATORY TRACT CONGESTION 45 0.0028
713 SEROTONIN SYNDROME 54 0.0028
714 SYNCOPE 280 0.0028
715 EXPIRED PRODUCT ADMINISTERED 93 0.0028
716 FLUSHING 284 0.0028
717 GENERALISED TONIC-CLONIC SEIZURE 46 0.0028
718 CEREBROVASCULAR ACCIDENT 468 0.0028
719 NASAL CONGESTION 160 0.0027
720 IMMUNOSUPPRESSION 24 0.0027
721 INCREASED TENDENCY TO BRUISE 25 0.0027
722 GASTROENTERITIS VIRAL 49 0.0027
723 CHOLECYSTECTOMY 31 0.0027
724 BRONCHITIS 199 0.0027
725 MEDICATION ERROR 148 0.0027
726 PNEUMOTHORAX 42 0.0026
727 TACHYCARDIA 235 0.0026
728 SKIN REACTION 37 0.0026
729 POLLAKIURIA 109 0.0026
730 ORAL HERPES 51 0.0026
731 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
732 WHITE BLOOD CELL COUNT INCREASED 100 0.0026
733 IRON DEFICIENCY ANAEMIA 24 0.0026
734 RHINORRHOEA 168 0.0026
735 LIVER DISORDER 115 0.0026
736 TRANSIENT ISCHAEMIC ATTACK 87 0.0026
737 SOMNOLENCE 519 0.0026
738 DERMATITIS 54 0.0026
739 APPLICATION SITE PAIN 56 0.0025
740 CONSTIPATION 554 0.0025
741 DEPRESSED MOOD 134 0.0025
742 COVID-19 443 0.0025
743 OBSTRUCTIVE AIRWAYS DISORDER 28 0.0025
744 MYOCLONUS 30 0.0025
745 ABASIA 62 0.0025
746 INFECTION 359 0.0025
747 APPENDICITIS 23 0.0025
748 QUALITY OF LIFE DECREASED 33 0.0025
749 PHARYNGITIS 30 0.0024
750 MENTAL DISORDER 105 0.0024
751 BACTERIAL INFECTION 45 0.0024
752 RASH PRURITIC 130 0.0024
753 STATUS EPILEPTICUS 27 0.0024
754 ABDOMINAL PAIN 556 0.0024
755 ADRENAL INSUFFICIENCY 29 0.0024
756 FOOT FRACTURE 45 0.0024
757 ORAL PAIN 53 0.0024
758 PELVIC PAIN 43 0.0024
759 SUDDEN DEATH 25 0.0024
760 SUICIDAL IDEATION 216 0.0024
761 HAEMATOMA 61 0.0024
762 MULTIPLE SCLEROSIS RELAPSE 161 0.0023
763 HYPOPHAGIA 60 0.0023
764 THERAPY CHANGE 23 0.0023
765 ANGINA PECTORIS 67 0.0023
766 NERVOUSNESS 122 0.0023
767 CENTRAL NERVOUS SYSTEM LESION 32 0.0023
768 DEPRESSED LEVEL OF CONSCIOUSNESS 92 0.0023
769 EYE HAEMORRHAGE 31 0.0023
770 RESPIRATORY DISTRESS 64 0.0023
771 DEATH 1996 0.0023
772 VENTRICULAR EXTRASYSTOLES 24 0.0023
773 HAEMORRHOIDS 45 0.0023
774 DIARRHOEA 1486 0.0023
775 RETCHING 49 0.0023
776 BLOOD PRESSURE INCREASED 351 0.0023
777 ANAPHYLACTIC SHOCK 59 0.0023
778 LIMB INJURY 62 0.0023
779 INJECTION SITE EXTRAVASATION 28 0.0023
780 ACCIDENT 27 0.0023
781 ROTATOR CUFF SYNDROME 29 0.0023
782 MALNUTRITION 25 0.0022
783 HYPOACUSIS 96 0.0022
784 COORDINATION ABNORMAL 31 0.0022
785 THERAPY CESSATION 114 0.0022
786 LYMPHOCYTE COUNT DECREASED 39 0.0022
787 ACNE 167 0.0022
788 TOOTH INFECTION 29 0.0022
789 MUSCULOSKELETAL CHEST PAIN 34 0.0022
790 HEART RATE DECREASED 77 0.0022
791 HYPOTHYROIDISM 70 0.0022
792 GASTROINTESTINAL PAIN 24 0.0022
793 MACULAR DEGENERATION 26 0.0022
794 HIATUS HERNIA 28 0.0022
795 CYANOSIS 34 0.0022
796 TOOTH DISORDER 48 0.0022
797 SKIN LESION 59 0.0021
798 INCORRECT DOSE ADMINISTERED 487 0.0021
799 GLAUCOMA 41 0.0021
800 RASH MACULAR 73 0.0021
801 NEOPLASM 24 0.0021
802 COUGH 584 0.0021
803 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371 0.0021
804 PROCEDURAL PAIN 56 0.0020
805 CANDIDA INFECTION 34 0.0020
806 HOSPITALISATION 308 0.0020
807 RESPIRATORY FAILURE 146 0.0020
808 HYPERSOMNIA 57 0.0020
809 ECONOMIC PROBLEM 30 0.0020
810 EMOTIONAL DISORDER 61 0.0020
811 RECTAL HAEMORRHAGE 85 0.0020
812 OXYGEN SATURATION DECREASED 111 0.0020
813 NO THERAPEUTIC RESPONSE 24 0.0020
814 LABORATORY TEST ABNORMAL 58 0.0020
815 IRRITABILITY 118 0.0020
816 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 57 0.0019
817 MOOD ALTERED 53 0.0019
818 TENDONITIS 30 0.0019
819 BLOOD PRESSURE FLUCTUATION 46 0.0019
820 NOCTURIA 23 0.0019
821 PRODUCTIVE COUGH 90 0.0019
822 JOINT INJURY 40 0.0019
823 DRUG ERUPTION 33 0.0019
824 HERNIA 36 0.0019
825 BLOOD PRESSURE DECREASED 123 0.0018
826 CHRONIC KIDNEY DISEASE 139 0.0018
827 RESPIRATORY ARREST 50 0.0018
828 NEOPLASM MALIGNANT 120 0.0018
829 BLOOD POTASSIUM DECREASED 54 0.0018
830 HAIR TEXTURE ABNORMAL 24 0.0018
831 DEVICE DIFFICULT TO USE 118 0.0018
832 CONVULSION 101 0.0018
833 HALLUCINATION 133 0.0018
834 ORAL CANDIDIASIS 23 0.0017
835 FUNGAL INFECTION 58 0.0017
836 DIVERTICULITIS 48 0.0017
837 OEDEMA PERIPHERAL 207 0.0017
838 STAPHYLOCOCCAL INFECTION 56 0.0017
839 ULCER 27 0.0017
840 CATARACT 101 0.0017
841 DRUG TOXICITY 23 0.0017
842 BLOOD URINE PRESENT 32 0.0017
843 FEELING JITTERY 32 0.0017
844 CEREBRAL INFARCTION 41 0.0017
845 GASTRITIS 44 0.0017
846 HOT FLUSH 126 0.0017
847 MOUTH ULCERATION 35 0.0017
848 BONE PAIN 97 0.0017
849 PRODUCT USE COMPLAINT 26 0.0016
850 GASTROENTERITIS 24 0.0016
851 HAEMATURIA 56 0.0016
852 INJURY ASSOCIATED WITH DEVICE 33 0.0016
853 HYPOTENSION 325 0.0016
854 NEUROPATHY PERIPHERAL 154 0.0016
855 PSORIASIS 211 0.0016
856 HIP FRACTURE 51 0.0016
857 FLUID RETENTION 80 0.0016
858 DEHYDRATION 209 0.0016
859 SKIN BURNING SENSATION 112 0.0016
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
861 PRODUCT DOSE OMISSION 102 0.0016
862 CARDIAC DISORDER 146 0.0016
863 BLOOD PRESSURE ABNORMAL 31 0.0016
864 UPPER LIMB FRACTURE 31 0.0016
865 SKIN HAEMORRHAGE 23 0.0016
866 ANKLE FRACTURE 24 0.0015
867 UNRESPONSIVE TO STIMULI 40 0.0015
868 COLITIS ULCERATIVE 69 0.0015
869 INTENTIONAL DOSE OMISSION 44 0.0015
870 PANCREATITIS 81 0.0015
871 GASTRIC ULCER 29 0.0015
872 DEMENTIA 42 0.0015
873 ARRHYTHMIA 71 0.0015
874 BREAST CANCER FEMALE 40 0.0015
875 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
876 CEREBRAL HAEMORRHAGE 53 0.0015
877 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
878 ACUTE RESPIRATORY FAILURE 28 0.0015
879 SPINAL FRACTURE 29 0.0014
880 ORTHOSTATIC HYPOTENSION 25 0.0014
881 DYSPNOEA EXERTIONAL 54 0.0014
882 CHOLELITHIASIS 47 0.0014
883 SKIN IRRITATION 65 0.0014
884 SKIN EXFOLIATION 119 0.0014
885 LOCALISED INFECTION 34 0.0014
886 THERAPY INTERRUPTED 100 0.0014
887 GASTRIC DISORDER 48 0.0014
888 FRACTURE 26 0.0014
889 PREMATURE BABY 41 0.0014
890 ECZEMA 71 0.0014
891 INTESTINAL OBSTRUCTION 51 0.0014
892 SKIN CANCER 28 0.0013
893 APPLICATION SITE ERYTHEMA 34 0.0013
894 CIRCULATORY COLLAPSE 22 0.0013
895 PRODUCT PRESCRIBING ISSUE 28 0.0013
896 PRODUCT DOSE OMISSION ISSUE 377 0.0013
897 ANGER 43 0.0013
898 SEPSIS 141 0.0013
899 TOOTH LOSS 26 0.0013
900 DRUG DOSE OMISSION BY DEVICE 98 0.0013
901 ABNORMAL DREAMS 34 0.0012
902 PRODUCT AVAILABILITY ISSUE 28 0.0012
903 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
904 BRADYCARDIA 64 0.0012
905 RESTLESSNESS 43 0.0012
906 HAEMORRHAGE 121 0.0012
907 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
908 WITHDRAWAL SYNDROME 48 0.0011
909 BREAST CANCER 106 0.0011
910 ABNORMAL BEHAVIOUR 45 0.0011
911 NEEDLE ISSUE 33 0.0011
912 DRUG INTERACTION 179 0.0011
913 DRY SKIN 148 0.0011
914 SEPTIC SHOCK 48 0.0011
915 APPLICATION SITE PRURITUS 25 0.0011
916 TARDIVE DYSKINESIA 31 0.0011
917 FEMUR FRACTURE 34 0.0011
918 HALLUCINATION, VISUAL 23 0.0011
919 AGITATION 80 0.0011
920 ABDOMINAL PAIN LOWER 27 0.0011
921 MOOD SWINGS 34 0.0011
922 ACCIDENTAL OVERDOSE 39 0.0011
923 EMOTIONAL DISTRESS 129 0.0011
924 HYPOKALAEMIA 49 0.0011
925 PULMONARY EMBOLISM 100 0.0011
926 COMA 50 0.0010
927 THROMBOSIS 84 0.0010
928 DRUG ADMINISTRATION ERROR 32 0.0010
929 CARDIO-RESPIRATORY ARREST 43 0.0010
930 TOXICITY TO VARIOUS AGENTS 171 0.0010
931 RENAL DISORDER 47 0.0010
932 PRODUCT PRESCRIBING ERROR 24 0.0010
933 ATRIAL FIBRILLATION 98 0.0010
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33 0.0010
935 SKIN ULCER 25 0.0010
936 EXPOSURE VIA SKIN CONTACT 25 0.0010
937 DEVICE ISSUE 86 0.0010
938 TREATMENT NONCOMPLIANCE 52 0.0009
939 MENTAL STATUS CHANGES 26 0.0009
940 WHITE BLOOD CELL COUNT DECREASED 101 0.0009
941 DEEP VEIN THROMBOSIS 60 0.0009
942 CARDIOVASCULAR DISORDER 23 0.0009
943 NO ADVERSE EVENT 164 0.0009
944 HYPOXIA 31 0.0009
945 EPISTAXIS 65 0.0009
946 DIABETES MELLITUS 65 0.0009
947 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
948 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
949 PSYCHOTIC DISORDER 25 0.0008
950 RED BLOOD CELL COUNT DECREASED 24 0.0008
951 HYPOGLYCAEMIA 39 0.0008
952 CARDIAC ARREST 66 0.0008
953 FLATULENCE 45 0.0008
954 RHABDOMYOLYSIS 33 0.0008
955 LEUKOPENIA 39 0.0008
956 HEPATIC FUNCTION ABNORMAL 29 0.0008
957 DEVICE MALFUNCTION 54 0.0008
958 DEVICE BREAKAGE 29 0.0007
959 BLOOD GLUCOSE DECREASED 34 0.0007
960 DERMATITIS ATOPIC 37 0.0007
961 MYOCARDIAL INFARCTION 121 0.0007
962 HYPONATRAEMIA 39 0.0007
963 DEVICE DISLOCATION 30 0.0007
964 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
965 COLITIS 26 0.0007
966 VAGINAL HAEMORRHAGE 29 0.0007
967 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
968 EXTRA DOSE ADMINISTERED 24 0.0006
969 HAEMOGLOBIN DECREASED 60 0.0006
970 CARDIAC FAILURE 46 0.0006
971 ANAEMIA 109 0.0006
972 PLEURAL EFFUSION 34 0.0006
973 PULMONARY OEDEMA 25 0.0006
974 DRUG ABUSE 46 0.0006
975 HAEMATOCHEZIA 30 0.0005
976 AGGRESSION 27 0.0005
977 DRUG DOSE OMISSION 81 0.0005
978 PRODUCT SUBSTITUTION ISSUE 28 0.0005
979 BLOOD CREATININE INCREASED 30 0.0005
980 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
981 DRUG WITHDRAWAL SYNDROME 37 0.0004
982 SUICIDE ATTEMPT 24 0.0004
983 RENAL FAILURE 50 0.0004
984 CARDIAC FAILURE CONGESTIVE 30 0.0004
985 BLOOD GLUCOSE INCREASED 68 0.0004
986 DISEASE PROGRESSION 42 0.0004
987 RENAL IMPAIRMENT 27 0.0003
988 ACUTE KIDNEY INJURY 49 0.0003
989 PLATELET COUNT DECREASED 33 0.0003
990 DRUG DEPENDENCE 45 0.0003
991 THROMBOCYTOPENIA 24 0.0002